Abiopharma

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0001839882-26-039473 <b>Size:</b> 866 KB

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0000950103-26-012172 <b>Size:</b> 314 KB

New Form DEFA14A - BNY Mellon Municipal Bond Infrastructure Fund, Inc. <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0002071844-26-001006 <b>Size:</b> 361 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0001213900-26-087699 <b>Size:</b> 140 KB

New Form 3 - TRUPANION, INC. <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0001371285-26-000175 <b>Size:</b> 3 KB

📋 Gilliam Joseph E (Officer) plans to sell 60K shares of GLAUKOS Corp (at $179.74 each, total $10.8M) Filed: Aug 11, 2026 | ID: 005874

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0000950103-26-012171 <b>Size:</b> 427 KB

📋 STUELPNAGEL JOHN R (Director) plans to sell 20K shares of 10x Genomics, Inc. (at $57.75 each, total $1.2M) Filed: Aug 11, 2026 | ID: 000152

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0000950103-26-012170 <b>Size:</b> 249 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0001918704-26-023466 <b>Size:</b> 820 KB